Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Contact Radiotherapy for Rectal Cancer (CORRECT): a Multicenter Randomized Phase II Trial

NCT06501053 is registered in ClinicalTrials.gov with Alexander Valdman as lead sponsor.

NCT NCT06501053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06501053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Contact Radiotherapy for Rectal Cancer (CORRECT): a Multicenter Randomized Phase II Trial
Lead sponsor
Alexander Valdman
Phase
Not applicable
Overall status
Recruiting
Start date
March 3, 2025
Completion date
November 30, 2032
Enrollment
110 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer